Free Trial

Adagio Medical (ADGM) Competitors

Adagio Medical logo
$1.40 -0.09 (-6.04%)
Closing price 02/21/2025 03:52 PM Eastern
Extended Trading
$1.47 +0.07 (+5.00%)
As of 02/21/2025 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ADGM vs. CRT, BRRR, GBBK, IVCP, BAYA, SELF, HUDA, BUJA, CLRC, and NBST

Should you be buying Adagio Medical stock or one of its competitors? The main competitors of Adagio Medical include Cross Timbers Royalty Trust (CRT), Valkyrie Bitcoin Fund (BRRR), Global Blockchain Acquisition (GBBK), Swiftmerge Acquisition (IVCP), Bayview Acquisition (BAYA), Global Self Storage (SELF), Hudson Acquisition I (HUDA), Bukit Jalil Global Acquisition 1 (BUJA), ClimateRock (CLRC), and Newbury Street Acquisition (NBST). These companies are all part of the "trading" industry.

Adagio Medical vs.

Adagio Medical (NASDAQ:ADGM) and Cross Timbers Royalty Trust (NYSE:CRT) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, media sentiment, valuation, dividends, community ranking, risk and profitability.

Cross Timbers Royalty Trust has higher revenue and earnings than Adagio Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adagio MedicalN/AN/A-$2.13MN/AN/A
Cross Timbers Royalty Trust$12.36M5.17$13.13M$1.129.52

Adagio Medical has a beta of 0.14, meaning that its share price is 86% less volatile than the S&P 500. Comparatively, Cross Timbers Royalty Trust has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500.

Cross Timbers Royalty Trust has a net margin of 88.08% compared to Adagio Medical's net margin of 0.00%. Cross Timbers Royalty Trust's return on equity of 262.62% beat Adagio Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Adagio MedicalN/A 160.59% 40.99%
Cross Timbers Royalty Trust 88.08%262.62%168.49%

48.1% of Adagio Medical shares are owned by institutional investors. Comparatively, 9.7% of Cross Timbers Royalty Trust shares are owned by institutional investors. 53.5% of Adagio Medical shares are owned by company insiders. Comparatively, 9.4% of Cross Timbers Royalty Trust shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Cross Timbers Royalty Trust had 3 more articles in the media than Adagio Medical. MarketBeat recorded 4 mentions for Cross Timbers Royalty Trust and 1 mentions for Adagio Medical. Adagio Medical's average media sentiment score of 0.99 beat Cross Timbers Royalty Trust's score of 0.49 indicating that Adagio Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Adagio Medical
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cross Timbers Royalty Trust
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Cross Timbers Royalty Trust received 158 more outperform votes than Adagio Medical when rated by MarketBeat users.

CompanyUnderperformOutperform
Adagio MedicalN/AN/A
Cross Timbers Royalty TrustOutperform Votes
158
65.29%
Underperform Votes
84
34.71%

Summary

Cross Timbers Royalty Trust beats Adagio Medical on 8 of the 11 factors compared between the two stocks.

Get Adagio Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADGM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADGM vs. The Competition

MetricAdagio MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$22.92M$4.71B$5.85B$9.15B
Dividend YieldN/A39.90%4.76%3.85%
P/E RatioN/A14.9116.5114.19
Price / SalesN/A52.72450.0276.60
Price / CashN/A51.1038.0134.95
Price / Book-0.406.577.644.63
Net Income-$2.13M$90.13M$3.18B$245.69M
7 Day Performance8.53%-2.20%-1.95%-2.68%
1 Month Performance70.94%-2.17%-0.23%-2.16%
1 Year PerformanceN/A15.26%16.69%12.90%

Adagio Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADGM
Adagio Medical
N/A$1.40
-6.0%
N/AN/A$22.92MN/A0.0087
CRT
Cross Timbers Royalty Trust
1.5064 of 5 stars
$10.41
+0.4%
N/A-38.3%$62.46M$12.36M9.29N/ADividend Cut
News Coverage
BRRR
Valkyrie Bitcoin Fund
N/A$27.54
+1.6%
N/A+85.5%$61.97MN/A0.00N/AHigh Trading Volume
GBBK
Global Blockchain Acquisition
N/A$11.30
-0.4%
N/A+6.3%$61.59MN/A0.002Short Interest ↓
High Trading Volume
IVCP
Swiftmerge Acquisition
N/A$8.78
-0.8%
N/A-17.8%$60.06MN/A-439.002,021Gap Down
BAYA
Bayview Acquisition
N/A$10.77
+0.2%
N/A+6.9%$58.59MN/A0.00N/ANews Coverage
Positive News
SELF
Global Self Storage
3.1514 of 5 stars
$5.15
-1.9%
$6.50
+26.2%
+18.8%$58.04M$12.19M19.0730
HUDA
Hudson Acquisition I
N/A$12.56
flat
N/AN/A$56.52MN/A0.00N/AHigh Trading Volume
BUJA
Bukit Jalil Global Acquisition 1
N/A$11.30
flat
N/A+8.5%$55.82MN/A0.00N/AHigh Trading Volume
CLRC
ClimateRock
N/A$12.04
-0.5%
N/A+6.2%$54.80MN/A0.002
NBST
Newbury Street Acquisition
N/A$11.06
flat
N/A+2.6%$54.75MN/A0.002

Related Companies and Tools


This page (NASDAQ:ADGM) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners